Is a combined oral contraceptive (COC) suitable for a 27-year-old female with migraine with aura and how can she be switched to a progestin-only pill (POP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraception in Women with Migraine with Aura

Combined oral contraceptives (COCs) are contraindicated in women with migraine with aura due to significantly increased stroke risk, and this 27-year-old female should be switched to a progestin-only pill or other non-estrogen containing contraceptive method. 1

Risk Assessment

Migraine with aura independently increases ischemic stroke risk (RR 2.16; 95% CI, 1.53-3.03) 1. When combined with COC use, this risk increases dramatically:

  • Meta-analyses show that oral contraceptive use in women with migraine with aura increases ischemic stroke risk by 7-fold (RR 7.02; 95% CI, 1.51–32.68) 1
  • The American Heart Association/American Stroke Association 2024 guidelines clearly state that for individuals with specific stroke risk factors including migraine with aura, progestin-only contraception or nonhormonal contraception is reasonable to prevent the increased stroke risk associated with estrogen-containing contraception 2

Recommended Contraceptive Options

For this 27-year-old woman with migraine with aura, the following options are appropriate:

  1. Progestin-only pills (POPs) - Safe with no increased stroke risk 1, 3
  2. Long-acting reversible contraceptives:
    • Levonorgestrel intrauterine device
    • Etonogestrel implant
    • Depot medroxyprogesterone acetate injections
  3. Non-hormonal methods:
    • Copper IUD
    • Barrier methods
    • Fertility awareness methods

How to Switch from COC to POP

To switch this patient from a combined oral contraceptive to a progestin-only pill:

  1. Immediate transition: Have the patient start the progestin-only pill (such as norethindrone 0.35mg or desogestrel 75mcg) the day after taking the last active COC pill
  2. No hormone-free interval: Unlike COCs, POPs are taken continuously without breaks
  3. Consistent timing: Advise taking the POP at the same time each day (within a 3-hour window) for optimal efficacy
  4. Backup contraception: Use backup contraception (condoms) for the first 48 hours after switching
  5. Bleeding pattern expectations: Inform the patient that irregular bleeding patterns are common with POPs, especially in the first few months 3

Benefits of Progestin-Only Methods

Beyond safety, progestin-only methods may offer additional benefits for migraine patients:

  • Research shows that desogestrel-containing POPs may actually reduce the number of migraine attacks and potentially improve aura symptoms 4
  • POPs avoid the estrogen withdrawal that can trigger headaches in some women 5

Important Monitoring Considerations

  1. Regular follow-up: Schedule follow-up at 3 months to assess:

    • Contraceptive efficacy and adherence
    • Changes in migraine pattern
    • Bleeding patterns
    • Side effects
  2. Warning signs requiring immediate attention:

    • Worsening headache pattern
    • New focal neurological symptoms
    • Signs of stroke (facial drooping, arm weakness, speech difficulties)

Common Pitfalls to Avoid

  1. Misinterpreting newer research: Some recent studies suggest that newer, lower-dose COCs may have less stroke risk 6, 7. However, the most recent guidelines from the American Heart Association/American Stroke Association (2024) still contraindicate estrogen-containing contraceptives in women with migraine with aura 2

  2. Inconsistent POP timing: Unlike COCs, POPs have a narrower window for effectiveness (typically 3 hours). Emphasize the importance of consistent timing to maintain contraceptive efficacy

  3. Ignoring additional risk factors: Assess for other stroke risk factors that would further increase risk (smoking, hypertension, age >35 years) 2, 1

By following these recommendations, you can provide safe and effective contraception for this 27-year-old woman with migraine with aura while minimizing her stroke risk.

References

Guideline

Contraception in Women with Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral contraceptives in migraine.

Expert review of neurotherapeutics, 2009

Research

Combined hormonal contraception and migraine: are we being too strict?

Current opinion in obstetrics & gynecology, 2019

Research

Combined hormonal contraceptives and migraine: An update on the evidence.

Cleveland Clinic journal of medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.